|No.||Article Type||Article Title||Article Page|
|1||Case Report||Thoracic Chordoma Misdiagnosed as Primary Adenocarcinoma of the Mediastinum||158 - 161|
|2||Case Report||Cor Triatriatum Associated with Total Anomalous Pulmonary Venous Connection: A Rare but Plausible Combination||143 - 145|
|3||Case Report||Robotic Intraoperative Tracheobronchial Repair during Minimally Invasive 3-Stage Esophagectomy||154 - 157|
|4||Case Report||Coronary Artery Bypass Grafting in an Infant after an Arterial Switch Operation||146 - 149|
|5||Case Report||Intractable Coronary Spasm Requiring Percutaneous Coronary Intervention after Coronary Artery Bypass Grafting in a Patient with Moyamoya Disease||150 - 153|
|6||Basic Research||Comparison of Hemodynamic Energy between Expanded Polytetrafluoroethylene and Dacron Artificial Vessels||81 - 87|
|7||Clinical Research||Impact of a Multidisciplinary Team Approach on Extracorporeal Circulatory Life Support-Bridged Heart Transplantation||99 - 105|
|8||Clinical Research||Mid-Term Outcomes and Angiographic Patency of Redo Coronary Artery Bypass Grafting: A Comparison between Off-Pump and On-Pump Surgery||106 - 116|
|9||Clinical Research||Effect of the Proximal Anastomosis Configuration of the Radial Artery in Patients Undergoing Coronary Artery Bypass Grafting||117 - 126|
|10||Clinical Research||Meta-Analysis of Limited Thymectomy versus Total Thymectomy for Masaoka Stage I and II Thymoma||127 - 136|
|11||Clinical Research||A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort||88 - 98|
|12||Clinical Research||Modus Operandi: Irrigation of the Modified Eloesser Flap in Heterogeneous Suppurative Lung Pathologies||137 - 142|
Last revised on December 01, 2020
The Journal of Chest Surgery (JCS) is a peer-reviewed official journal of the Korean Society for Thoracic and Cardiovascular Surgery (KSTCS). The journal is published bimonthly and its abbreviated title is J Chest Surg. The journal publishes outstanding research articles in thoracic and cardiovascular surgery and related fields. JCS is committed to providing a place of active communication for all thoracic surgeons, advancing our knowledge on thoracic and cardiovascular surgery including physiology, diagnosis, and treatment, and offering effective treatment and cure to the public ultimately. In addition to members of the society, any researcher throughout the world can submit a manuscript if the scope of the manuscript is appropriate. Manuscripts for submission to the journal should be prepared according to the following instructions. For issues not addressed in these instructions, the author is referred to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf) from the International Committee of Medical Journal Editors (ICMJE).
The journal adheres to the guidelines and best practices published by
professional organizations, including ICMJE Recommendations and the Principles of
Transparency and Best Practice in Scholarly Publishing (joint statement by the
Committee on Publication Ethics, COPE; the Directory of Open Access Journals, DOAJ;
the World Association of Medical Editors, WAME; and Open Access Scholarly Publishers
Association, OASPA; https://doaj.org/bestpractice). Furthermore, all processes
of handling research and publication misconduct shall follow the applicable COPE
The manuscript that has been published previously or is currently under consideration for publication elsewhere will not be accepted for publication of JCS. Also, the manuscript that has been accepted in JCS should not be duplicately published in other journals. However, in the case of the thesis for a degree, the major contents can be introduced in accordance with a rule of “Key Reference”.
It is recommended that any research dealing with a clinical
trial be registered with a primary national clinical trial registration
site such as Clinical Research Information Service
(https://cris.nih.go.kr), or other sites accredited by the
Health Organization International Clinical Trials Registry
Platform (http://www.who.int/ictrp/en) and ClinicalTrials.
gov (http://clinicaltrials.gov), a service of the United States
National Institutes of Health.
The corresponding author must inform the editor of any
potential conflicts of interest that could influence the authors’
interpretation of the data. Examples of potential conflicts
of interest are financial support from or connections to
pharmaceutical companies, political pressure from interest
groups, and academically related issues.
Copies of written informed consent or Institutional Review
Board (IRB) approval for any manuscripts involving human
or human products should be kept. If necessary, the editor or
reviewers may request copies of these documents to resolve
questions about IRB approval and study conduct. In addition,
for studies conducted with human subjects, the method
by which informed consent was obtained from the participants
(i.e., verbal or written) also needs to be stated in the
All human investigations must be conducted according to
the principles expressed in the Declaration of Helsinki
(https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/). Indicate whether or not your IRB (or Ethics
Committee or comparable group) approved this study and
whether or not individual consent for the study was obtained
or waived. When animals are used as subjects, institutional
approval of the protocol is necessary and authors should include
a statement in methods indicating that investigators
complied with the Institutional Animal Care and Use Committee
or an equivalent guideline.
All authors must have made a significant intellectual contribution to the manuscript according to the criteria formulated by the International Committee of Medical Journal Editors. Authorship credit should be based on (1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet these four conditions. Before publication of an accepted manuscript, each author is required to certify by signing the conditions for Publication Form that he or she has participated sufficiently in the work to take responsibility for a meaningful share of the content of the manuscript. An image file of the conditions for publication form signed by all authors should be attached to the manuscript.
When the journal faces suspected cases of research and
publication misconduct such as redundant (duplicate) publication,
plagiarism, fraudulent or fabricated data, changes in
authorship, an undisclosed conflict of interest, ethical problems
with a submitted manuscript, a reviewer who has appropriated
an author’s idea or data, complaints against editors,
and so on, the resolution process will follow the
flowchart provided by the Committee on Publication Ethics
(http://publicationethics.org/resources/flowcharts). The discussion
and decision on the suspected cases are carried out
by the Editorial Board.
The Editorial Board will continuously work to monitor
and safeguard publication ethics: guidelines for retracting articles;
maintenance of the integrity of the academic record;
preclusion of business needs from compromising intellectual
and ethical standards; publishing corrections, clarifications,
retractions, and apologies when needed; and excluding plagiarism
and fraudulent data. The editors maintain the following
responsibilities: responsibility and authority to reject
and accept articles; avoiding any conflict of interest with respect
to articles they reject or accept; promoting publication
of corrections or retractions when errors are found; and preservation
of the anonymity of reviewers.
Copyright in all published material is owned by the KSTCS.
Authors must agree to transfer copyright during the submission
process. The corresponding author is responsible for submitting
the copyright transfer agreement to the publisher.
JCS is an open access journal. Articles are distributed
under the terms of the Creative Commons Attribution License
which permits unrestricted noncommercial use, distribution,
and reproduction in any medium, provided the original work
is properly cited. Author(s) do not need to be permitted for
use of tables or figures published in JCS in other journals,
books, or media for scholarly and educational purposes.
This is in accordance with the Budapest Open Access Initiative
definition of open access.
The full text of JCS has been archived in PubMed
National Library of Korea (https://www.nl.go.kr/) from the
1th issue of Volume 44, 2011. According to the deposit policy
(self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk/), authors cannot archive pre-print (i.e., pre-refereeing),
but they can archive post-print (i.e., final draft post-refereeing).
Authors can archive publisher’s version/PDF.
JCS encourages data sharing wherever possible, unless this is prevented by ethical, privacy, or confidentiality matters. Authors wishing to do so may deposit their data in a publicly accessible repository and include a link to the DOI within the text of the manuscript.
All manuscripts should be submitted online via the journal’s website (http://www.jchestsurg.org/submission/) with written consents containing all the authors’ signatures on copyright transfer by the corresponding author, and author’s checklist. And all the reviewing and editing is also performed via this system. Microsoft Word is the preferred software program. Any questions and answers regarding the review process and other related matters can be checked on the above on-line system. In addition, whenever any changes are made during the process of a review of the manuscripts, the relevant information is forwarded to the corresponding author and the first author. Authors can submit their manuscripts throughout the year, and the date of receipt will be the day when the Editorial Board receives the draft. Accepted manuscripts for publication by the journal will be sent to authors for proofreading after printing. All accepted manuscripts are processed by system of to prevent any issues concerning plagiarism and authors can be asked to revise manuscript by editor. After that, the editor will proofread the draft more than one time. Unless special requests are made, the society will not be obligated to return the draft, regardless of its publication.
The editors reserve the right to improve the style and, if necessary, return the manuscript to the author for revision.
Manuscripts are categorized as editorial, basic/clinical research, case report, how-to-do it, classics in thoracic surgery, collective of current review, lecture, brief communication or correspondence, and key reference. The abstracts and discussions of the annual meetings or conferences can be published.
Manuscripts should be written primarily in English. Medical terminology should be written based on the most recent edition of Dorland’s Illustrated Medical Dictionary.
The main document with manuscript text and tables should be prepared with Microsoft Word.
For the specific study design, such as randomized control studies, studies of diagnostic accuracy, meta-analyses, observational studies, authors are encouraged to also consult the reporting guidelines relevant to their specific research design. A good source of reporting guidelines is the EQUATOR Network (https://www.equator-network.org/) and the NLM (https:// www.nlm.nih.gov/services/research_report_guide.html).
Table 1 shows the recommended maximums of manuscripts according to publication type; however, these requirements are negotiable with the editor.
|Categorya)||Text(word)b)||Abstract(word)||Tables & Figures||References||Keywords|
|Basic/Clinical research||5,000||SA, 250||10||30||5|
|Case report||1,500||UA, 150||3||10||5|
|Historical note||5,000||UA, 150||10||20||5|
The manuscript should be arranged in the following order: title page, abstract and keywords, main text (introduction, methods, results, and discussion), conflict of interest, (acknowledgments, Funding), ORCID, references, tables, and figure legends.
The only abstract of research articles should contain the following components in the order listed: Background, Methods, Results, and Conclusion. It should be no more than 250 words. Keywords with a maximum of 5 items should be listed at the end of the Abstract. If keywords are not on the list published in volume 34-1 (January 2001) or on the keywords dictionary of the Journal, they can be based on Medical Subject Heading (MeSH) of Medline (https://meshb.nlm.nih.gov). And keywords should begin with a capital letter and may be revised by the Editorial Board. However, at least one obligatory keyword should be selected from the appended list (obligatory keywords) of each volume of the journal.
The main text should be arranged in this order: Introduction, Methods, Results, and Discussion. Every reference, figure, and table must be cited numerically in the order mentioned in the text.
A potential conflict of interest should be disclosed in the manuscript even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may be financial support or private connections to pharmaceutical companies, political pressure from interest groups, or academic problems (e.g., employment/affiliation, grants or funding, consultancies, stockownership or options, royalties, or patents filed, received, or pending). Any members of Editorial board of JCS must declare that he or she is an Editorial Board of JCS, however, did not involve in the peer reviewer selection, evaluation, and decision process of this article. Otherwise, no potential conflict of interest relevant to this article was reported.
The acknowledgments should be presented after the main text and before the reference list. Persons who have contributed intellectually to the paper but whose contributions do not justify authorship may be named and their function or contribution described, e.g., scientific adviser, data collection, or participation in clinical trial.
All sources of funding applicable to the study should be stated here explicitly. All original articles, editorials, reviews, and new technology articles must state sources of funding for this study.
All authors are recommended to provide an ORCID. To obtain an ORCID, authors should register in the ORCID web site: https://orcid.org. Registration is free to every researcher in the world.
In the text, references should be cited with Arabic numerals in brackets and numbered in the order cited. The abbreviated journal title shall be used according to the NLM Catalog: Journals referenced in the NCBI Databases (http://www.ncbi.nlm.nih.gov/nlmcatalog/journals) and the Journal Browser of KoreaMed (https://www.koreamed.org/JournalBrowserNew.php). References should be numbered consecutively in the order in which they are first mentioned in the text. Each reference should be cited as [1,2], or [3-5], Kim and Jang , or Park et al. . Six authors can be listed. If there are more than 6 authors, only list the first 3 names with “et al.” Unpublished observations and personal communication should not be used as references, although references to written, not oral communication may be inserted (in parentheses) in the text. For more on references, refer to the Citing Medicine: the NLM Style Guide for Authors, Editors, and Publishers (http://www.nlm.nih.gov/citingmedicine). Sample references are given below:
Tables should be double-spaced and inserted on a separate page at the end of the text document, with the table number, table title, and legend. The numbers should be allocated accordingly in order in which the table was quoted in the main text. The title and contents of a table should be concise and clear, so that a reader can understand the table without referring to the text. Each column should be given a short heading. Only the first letter of the first word in each row and column should be capital letters. Tables should be written as “Table” in the text. No vertical or horizontal lines are allowed to be included within a table. The statistical significance of observed differences in the data should be indicated by the appropriate statistical analysis. Statistical measures such as SD or SE should be identified. All nonstandard abbreviations should be defined in footnotes. A table should not exceed one page when printed. Use lower case letters in superscripts a), b), c) ... for special remarks. Each mark must be defined in a footnote.
Each figure should be submitted in a separate file. They should be submitted in EPS, TIF, JPEG, or PPT format. The figures should be sized to column width (8.5 or 17.5 cm). The figure images should be provided in high resolution (preferably 600 dpi for figures and 1,200 dpi for line art and graphs). Figures should be numbered in the form Fig. 1, Fig. 2, and Fig. 3 using Arabic numerals, in the order in which they are cited. Related figures should be combined into one figure, with each subfigure denoted by the letters, A, B, C, and so on, following the Arabic number of the main figure (e.g., Fig. 1A, Fig. 1B, C). Titles and detailed explanations belong in the figure legends, not on the illustrations themselves. Microscopic images should be described with staining method and magnification rate (e.g., H&E, ×400). Electron microscopic photographs should have an internal scale marker. Figures can be marked with arrows, letters, or other indicators, if necessary. Figure legends should consist of a one-sentence description rather than a phrase or a paragraph. If the figures are not original, the author must contact each publisher to request permission and this should be remarked on in the footnote to the figure.
All other types of manuscripts should meet the above-mentioned requirements.
Review article shall be limited to an invited review article, which, by the Editorial Board, was selected as a significant theme from areas relevant to thoracic and cardiovascular surgery field and whose authors were selected and referred on the basis of articles published in this or other journals. The submitted manuscript should be decided to be published via reviewing of the Editorial Board. It should include a title page, abstract and keywords, introduction, body text, conclusion, conflict of interest, (acknowledgments, funding), ORCID, references, tables, and figure legends. There should be an unstructured abstract less than or equal to 250 words.
Case report shall cope with states of diseases that has not been reported or has rarely seen, and those that had been already reported but are distinctively different from the previous reports can be published in this journal. Its abstract, unlike those for research articles, shall have only one paragraph and be written within 150 words. Its cover should include the phrase “Case Report”, and its title cannot include “… case” or “A case of.” It should include title page, abstract and keywords, case report(s), discussion, conflict of interest, (acknowledgments, funding), ORCID, references, tables, and figure legends. Its discussion shall focus on what the case report emphasizes.
Editorials are invited perspectives on an area of thoracic and cardiovascular surgery, dealing with fields of research, current medical interests, fresh insights and debates. No abstract is required for Editorial.
Brief Communication is comments or opinion of reviewer (or other readers). Correspondence is a letter from author (or reviewers) to editor. No abstract is required and do not include tables.
“How to Do It” article should be a description of a useful surgical technique or innovative concept, and contain descriptive, illustrative material.
Describe breakthrough achievements that led to the development of thoracic surgery in Korea. These articles may include biographical heritage of the KTCVS. These articles must be proved by official organization.
After a paper has been accepted for publication, the author(s) should submit the final version of the manuscript. The names and affiliations of authors should be double-checked, and if the originally submitted image files were of poor resolution, higher resolution image files should be submitted at this time. Symbols (e.g., circles, triangles, squares), letters (e.g., words, abbreviations), and numbers should be large enough to be legible on reduction to the journal’s column widths. All symbols must be defined in the figure caption. If references, tables, or figures are moved, added, or deleted during the revision process, renumber them to reflect such changes so that all tables, references, and figures are cited in numeric order.
Before publication, the manuscript editor will correct the manuscript such that it meets the standard publication format. The author(s) must respond within 48 hours when the manuscript editor contacts the author for revisions. If the response is delayed, the manuscript’s publication may be postponed to the next issue.
The author(s) will receive the final version of the manuscript as a PDF file. Upon receipt, the author(s) must notify the editorial office (or printing office) of any errors found in the file within 48 hours. Any errors found after this time are the responsibility of the author(s) and will have to be corrected as an erratum.
To correct errors in published articles, the corresponding author should contact the journal’s editorial office with a detailed description of the proposed correction. Corrections that profoundly affect the interpretation or conclusions of the article will be reviewed by the editors. Corrections will be published as corrigenda (corrections of author’s errors) or errata (corrections of publisher’s errors) in a later issue of the journal.
There is no author’s submission fee and other publication- related fees as publication costs are shouldered by the publisher. Revenue sources of journal are from the support of publisher (KTCVS).
Send all correspondence regarding submitted manuscripts to:
The Editorial Office of the Korean Society for Thoracic and Cardiovascular Surgery, 101-401 Seoul Station Liga, 21 Mallijae-ro 33-gil, Jung-gu, Seoul 04501, Korea
Tel: +82-31-709-0918, Fax: 02-3482-7868
Editor e-mail: email@example.com,
Journal’s website: http://www.jchestsurg.org
NOTICE: These recently revised instructions for authors will be applied beginning with the February 2021 issue.
Korean Journal of Thoracic and Cardiovascular Surgery 2019; 52(3): 125-130
Korean Journal of Thoracic and Cardiovascular Surgery 2019; 52(3): 131-140
Korean Journal of Thoracic and Cardiovascular Surgery 2019; 52(3): 141-147
Jae Suk Yoo, M.D., Yong Jin Kim, M.D., Soo Hwan Kim, and Seung Hwa Choi
Korean J Thorac Cardiovasc Surg 2011; 44(3): 197-207
Jae Bum Park, Seung Ho Bang, Hyun Keun Chee, Jun Seok Kim, Song Am Lee, and Je Kyoun Shin
Korean J Thorac Cardiovasc Surg 2014; 47(3): 249-254
Jinhae Nam, M.D., Sun-Young Choi, M.D., Si-Chan Sung, M.D. Ph.D., Hong-Gook Lim, M.D. Ph.D., Seong-sik Park, M.D. Ph.D., Soo-Hwan Kim, M.D., and Yong Jin Kim, M.D. Ph.D.
Korean J Thorac Cardiovasc Surg 2012; 45(6): 380-389